This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Pathologic Targets in Rheumatoid Arthritis: Modifying the Immune Response to Optimize Patient Outcomes

Pathologic Targets in Rheumatoid Arthritis: Modifying the Immune Response to Optimize Patient Outcomes



Time to Complete

1 hour


February 23, 2018


February 23, 2019
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CE for Nurses

Accredited Provider

Jointly provided by Med Learning Group and Ultimate Medical Academy/Complete Conference Management

Commercial Supporter

Supported by educational grant from Lilly

Program Description

This online activity is focused on the care of patients with rheumatoid arthritis (RA).

To order 3D glasses, please click here.

Intended Audience

This activity is designed to meet the educational needs of rheumatologists, nurses and allied healthcare professionals involved in the care of patients with rheumatoid arthritis.

Educational Objectives

Upon completion of the program, participants should be able to:

  • Describe the treatment combinations for patient with moderate-to-severe RA after MTX failure or intolerance
  • Integrate clinical trials data of targeted therapy into the treatment of patients with moderate-to-severe RA
  • Discuss the pathogenesis and risk of cardiovascular disease in patients with RA and the co-management of both conditions
  • Review strategies to optimize patient outcomes through their participation in the RA care plan

Conflict Of Interest Disclosure Policy

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


Jon T. Giles, MD, MPH
Associate Professor of Medicine
Division of Rheumatology
Columbia University
College of Physicians and Surgeons
New York, NY

Dr. Giles serves as a consultant for Roche/Genentech and Lilly. He has received support from NIH/NIAMS, American College of Rheumatology Research and Education Foundation, Arthritis Foundation, Arthritis National Research Foundation, and Pfizer. He is on the DSMB for Coherus.

Gregg J. Silverman, MD
Professor of Medicine and Pathology
Director, Laboratory of B cell Immunobiology
NYU School of Medicine
New York, NY

Dr. Silverman serves as a consultant for Genentech, Eli Lilly, BMS, and Roche and is on the speaker board for Genentech and Bristol Myers Squibb. He has received support from the Arthritis Foundation, Lupus Research Institute, Rheumatology Research Foundation, and NIH. He is a consultant for Regeneron. A family member is employed by Gilead.

Planners, Managers, and Reviewers Disclosures

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Ana Maria Albino, Program Manager for Med Learning Group, has nothing to disclose.
Flavia Piazza, PhD, VP Medical and Scientific Services for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group, has nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Med Learning Group designates this enduring activity for a maximum of 1.00 AMA Category 1 Credit(s)TM  . Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.




CE for Nurses

Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

Awarded 1.00 contact hour(s) of continuing nursing education of RNs and APNs.

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐ approved indications.


Med Learning Group makes every effort to develop CME activities that are scientifically based.

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision‐making before applying any information, whether provided here or by others, for any professional use.


To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For CME questions, please contact: Med Learning Group at


Copyright © 2017 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue